Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities
Net income (loss)	$ (17)	$ (41)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	60	81
Stock-based compensation expense	9	13
Deferred income taxes	(6)	6
Loss (gain) on divestiture	0	(7)
Changes in assets and liabilities, net of effects of business acquired:
Receivables	(31)	17
Inventories	(14)	0
Current payables and accrued expenses	(30)	(61)
Contract liabilities	9	61
Employee benefit plans	8	(3)
Other assets and liabilities	(30)	(101)
Net cash provided by (used in) operating activities	(42)	(35)
Investing activities
Expenditures for property, plant and equipment	(8)	(8)
Additions to capitalized software	(31)	(53)
Proceeds from divestiture, net	0	7
Collections on purchased trade receivables	4	0
Net cash provided by (used in) investing activities	(35)	(54)
Financing activities
Payments on term credit facilities	0	(4)
Payments on revolving credit facilities	(7)	(122)
Borrowings on revolving credit facilities	7	220
Cash dividend paid for Series A preferred shares dividends	(4)	(4)
Repurchases of common stock	(62)	0
Proceeds from employee stock plans	2	0
Tax withholding payments on behalf of employees	(6)	(8)
Principal payments for finance lease obligations	(4)	(2)
Net cash provided by (used in) financing activities	(74)	80
Effect of exchange rate changes on cash, cash equivalents and restricted cash	1	(7)
Increase (decrease) in cash, cash equivalents, and restricted cash	(150)	(16)
Cash, cash equivalents and restricted cash at beginning of period	758	285
Cash, cash equivalents and restricted cash at end of period	$ 608	$ 269